AngioDynamics, Inc. (ANGO) Free cash flow
- Free cash flow · 12 months (USD): Value $508.00K; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-05-31..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-05-31..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-05-31..
- Free cash flow margin · 12 months: Value 0.16%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-05-31..
Free cash flow
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $508.00K | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-05-31. $3.09M − $2.58M ≈ $508.00K |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 0.16% | (Operating cash flow − capital spending) / revenue. Period ending 2026-05-31. $508.00K ÷ $320.17M × 100 ≈ 0.16% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $3.09M | Cash generated by operating activities. Period ending 2026-05-31. |
| Operating cash flow / net income · 12 months | -0.08× | Operating cash flow / net income. Period ending 2026-05-31. $3.09M ÷ $-36.74M ≈ -0.08× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 3.09M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 2.58M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 508.00K USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 320.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -36.74M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $508.00K | (m) | $3.09M | $2.58M | (m) | $320.17M | (m) | $-36.74M | (m) | (m) | 0.16% | -0.08× |
| 2026-02-28 | $1.50M | (m) | $4.45M | $2.94M | (m) | $313.73M | (m) | $-31.39M | (m) | (m) | 0.48% | -0.14× |
| 2025-11-30 | $-9.33M | (m) | $-5.60M | $3.73M | (m) | $307.31M | (m) | $-27.71M | (m) | (m) | -3.04% | 0.20× |
| 2025-08-31 | $-11.89M | (m) | $-7.79M | $4.10M | (m) | $300.72M | (m) | $-32.10M | (m) | (m) | -3.95% | 0.24× |
| 2025-05-31 | $-14.59M | (m) | $-10.13M | $4.46M | (m) | $292.50M | (m) | $-33.99M | (m) | (m) | -4.99% | 0.30× |
| 2025-02-28 | $-28.19M | (m) | $-23.94M | $4.25M | (m) | $283.32M | (m) | $-41.39M | (m) | (m) | -9.95% | 0.58× |
| 2024-11-30 | $-26.37M | (m) | $-23.30M | $3.06M | (m) | $286.50M | (m) | $-224.72M | (m) | (m) | -9.20% | 0.10× |
| 2024-08-31 | $-23.33M | (m) | $-20.51M | $2.82M | (m) | $292.73M | (m) | $-243.03M | (m) | (m) | -7.97% | 0.08× |
| 2024-05-31 | $-30.68M | (m) | $-28.16M | $2.52M | (m) | $303.91M | (m) | $-184.35M | (m) | (m) | -10.09% | 0.15× |
| 2024-02-29 | $-20.21M | (m) | $-17.20M | $3.01M | (m) | $324.01M | (m) | $-192.37M | (m) | (m) | -6.24% | 0.09× |
| 2023-11-30 | $-6.38M | (m) | $-3.31M | $3.07M | (m) | $329.54M | (m) | $-14.12M | (m) | (m) | -1.93% | 0.23× |
| 2023-08-31 | $-4.87M | (m) | $-1.08M | $3.79M | (m) | $335.89M | (m) | $6.45M | (m) | (m) | -1.45% | -0.17× |
| 2023-05-31 | $-3.73M | (m) | $78.00K | $3.81M | (m) | $338.75M | (m) | $-52.44M | (m) | (m) | -1.10% | -0.00× |
| 2023-02-28 | $-11.11M | (m) | $-7.32M | $3.79M | (m) | $334.68M | (m) | $-37.24M | (m) | (m) | -3.32% | 0.20× |
| 2022-11-30 | $-21.71M | (m) | $-17.48M | $4.24M | (m) | $327.93M | (m) | $-32.71M | (m) | (m) | -6.62% | 0.53× |
| 2022-08-31 | $-27.12M | (m) | $-23.04M | $4.08M | (m) | $320.79M | (m) | $-32.58M | (m) | (m) | -8.45% | 0.71× |
| 2022-05-31 | $-11.49M | (m) | $-7.19M | $4.30M | (m) | $316.22M | (m) | $-26.55M | (m) | (m) | -3.63% | 0.27× |
| 2022-02-28 | $-7.43M | (m) | $-3.56M | $3.88M | (m) | $306.06M | (m) | $-39.75M | (m) | (m) | -2.43% | 0.09× |
| 2021-11-30 | $6.95M | (m) | $11.11M | $4.15M | (m) | $303.27M | (m) | $-38.34M | (m) | (m) | 2.29% | -0.29× |
| 2021-08-31 | $16.23M | (m) | $20.61M | $4.38M | (m) | $297.76M | (m) | $-34.25M | (m) | (m) | 5.45% | -0.60× |
| 2021-05-31 | $18.91M | (m) | $24.09M | $5.19M | (m) | $291.01M | (m) | $-31.55M | (m) | (m) | 6.50% | -0.76× |
| 2021-02-28 | $9.73M | (m) | $15.77M | $6.05M | (m) | $272.50M | (m) | $-169.15M | (m) | (m) | 3.57% | -0.09× |
| 2020-11-30 | $-14.34M | (m) | $-7.93M | $6.41M | (m) | $271.10M | (m) | $-171.31M | (m) | (m) | -5.29% | 0.05× |
| 2020-08-31 | $-21.11M | (m) | $-13.45M | $7.67M | (m) | $268.33M | (m) | $-169.78M | (m) | (m) | -7.87% | 0.08× |
| 2020-05-31 | $-21.79M | (m) | $-14.55M | $7.24M | (m) | $264.16M | (m) | $-166.79M | (m) | (m) | -8.25% | 0.09× |
| 2020-02-29 | $7.00K | (m) | $6.58M | $6.57M | (m) | $277.01M | (m) | $49.15M | (m) | (m) | 0.00% | 0.13× |
| 2019-11-30 | $27.04M | (m) | $32.76M | $5.72M | (m) | $272.75M | (m) | $55.66M | (m) | (m) | 9.91% | 0.59× |
| 2019-08-31 | $35.95M | (m) | $39.78M | $3.83M | (m) | $272.73M | (m) | $60.53M | (m) | (m) | 13.18% | 0.66× |
| 2019-05-31 | $34.32M | (m) | $37.44M | $3.12M | (m) | $270.63M | (m) | $61.34M | (m) | (m) | 12.68% | 0.61× |
| 2019-02-28 | $33.15M | (m) | $36.20M | $3.05M | (m) | $351.50M | (m) | $4.57M | (m) | (m) | 9.43% | 7.92× |
| 2018-11-30 | $29.59M | (m) | $32.17M | $2.58M | (m) | $349.01M | (m) | $17.79M | (m) | (m) | 8.48% | 1.81× |
| 2018-08-31 | $26.81M | (m) | $29.38M | $2.57M | (m) | $344.21M | (m) | $15.90M | (m) | (m) | 7.79% | 1.85× |
| 2018-05-31 | $38.90M | (m) | $41.29M | $2.39M | (m) | $344.29M | (m) | $16.34M | (m) | (m) | 11.30% | 2.53× |
| 2018-02-28 | $34.12M | (m) | $36.51M | $2.39M | (m) | $342.88M | (m) | $1.32M | (m) | (m) | 9.95% | 27.66× |
| 2017-11-30 | $44.18M | (m) | $46.56M | $2.38M | (m) | $344.63M | (m) | $-9.81M | (m) | (m) | 12.82% | -4.75× |
| 2017-08-31 | $48.32M | (m) | $51.34M | $3.02M | (m) | $346.96M | (m) | $3.67M | (m) | (m) | 13.93% | 13.98× |
| 2017-05-31 | $52.74M | (m) | $55.74M | $3.00M | (m) | $349.64M | (m) | $5.01M | (m) | (m) | 15.09% | 11.13× |
| 2017-02-28 | $52.61M | (m) | $55.30M | $2.69M | (m) | $356.15M | (m) | $-25.15M | (m) | (m) | 14.77% | -2.20× |
| 2016-11-30 | $50.32M | (m) | $53.33M | $3.00M | (m) | $357.98M | (m) | $-27.45M | (m) | (m) | 14.06% | -1.94× |
| 2016-08-31 | $45.89M | (m) | $47.96M | $2.06M | (m) | $358.24M | (m) | $-41.52M | (m) | (m) | 12.81% | -1.16× |
| 2016-05-31 | $42.89M | (m) | $45.22M | $2.33M | (m) | $353.89M | (m) | $-43.59M | (m) | (m) | 12.12% | -1.04× |
| 2016-02-29 | $34.68M | (m) | $37.48M | $2.80M | (m) | $351.22M | (m) | $-1.30M | (m) | (m) | 9.87% | -28.76× |
| 2015-11-30 | $31.73M | (m) | $37.31M | $5.58M | (m) | $350.43M | (m) | $-6.20M | (m) | (m) | 9.05% | -6.02× |
| 2015-08-31 | $18.01M | (m) | $25.59M | $7.58M | (m) | $353.35M | (m) | $-4.50M | (m) | (m) | 5.10% | -5.69× |
| 2015-05-31 | $14.30M | (m) | $26.24M | $11.94M | (m) | $356.97M | (m) | $-3.27M | (m) | (m) | 4.01% | -8.03× |
| 2015-02-28 | $11.74M | (m) | $24.94M | $13.21M | (m) | $360.14M | (m) | $-3.67M | (m) | (m) | 3.26% | -6.80× |
| 2014-11-30 | $624.00K | (m) | $12.13M | $11.50M | (m) | $361.69M | (m) | $5.11M | (m) | (m) | 0.17% | 2.37× |
| 2014-08-31 | $8.76M | (m) | $22.73M | $13.97M | (m) | $358.11M | (m) | $3.51M | (m) | (m) | 2.45% | 6.48× |
| 2014-05-31 | $13.51M | (m) | $25.28M | $11.77M | (m) | $354.45M | (m) | $3.09M | (m) | (m) | 3.81% | 8.19× |
| 2014-02-28 | $13.13M | (m) | $26.54M | $13.41M | (m) | $350.42M | (m) | $3.71M | (m) | (m) | 3.75% | 7.14× |
| 2013-11-30 | $22.60M | (m) | $37.13M | $14.52M | (m) | $343.80M | (m) | $-2.38M | (m) | (m) | 6.57% | -15.57× |
| 2013-08-31 | $25.74M | (m) | $39.80M | $14.05M | (m) | $342.20M | (m) | $-317.00K | (m) | (m) | 7.52% | -125.54× |
| 2013-05-31 | $14.76M | (m) | $26.88M | $12.12M | (m) | $342.03M | (m) | $-612.00K | (m) | (m) | 4.32% | -43.93× |
| 2013-02-28 | $6.19M | (m) | $14.51M | $8.32M | (m) | $309.68M | (m) | $-6.77M | (m) | (m) | 2.00% | -2.14× |
| 2012-11-30 | $5.08M | (m) | $11.30M | $6.22M | (m) | $279.68M | (m) | $-7.55M | (m) | (m) | 1.82% | -1.50× |
| 2012-08-31 | $-80.00K | (m) | $2.84M | $2.92M | (m) | $250.76M | (m) | $-7.19M | (m) | (m) | -0.03% | -0.39× |
| 2012-05-31 | $9.01M | (m) | $11.50M | $2.49M | (m) | $221.79M | (m) | $-5.09M | (m) | (m) | 4.06% | -2.26× |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | $30.91M | (m) | $33.87M | $2.96M | (m) | $215.75M | (m) | $8.12M | (m) | (m) | 14.33% | 4.17× |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-05-31 | $34.92M | (m) | $39.96M | $5.04M | (m) | $216.03M | (m) | $12.31M | (m) | (m) | 16.16% | 3.25× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |